BioNTech SE ADR (BNTX)

概要ニュース株価時系列オプションチェーンなぜBNTXが下落しているのか？ディスカッション予測株の配当実績

なぜBioNTech SE ADR（BNTX）の株価が下がっていますか？

2024-03-20 の取引セッション中に、BioNTech SE ADR (BNTX) 株の 5.02% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。

2023-10-16:

Shares of BioNTech Se (BNTX) dropped by 6.38% from $103.58 to $96.97 in the trading on Monday, October 16, 2023. The reasons why BNTX stock down include:

Pfizer's sales outlook cut: BioNTech's partner, Pfizer, decided to slash its full-year sales expectations by $9 billion, citing a shift towards the commercial approval of its Paxlovid COVID treatment and other factors. The impact of Pfizer's news rippled through the pharmaceutical sector, causing declines in the shares of BioNTech.
Downgrade rating: BioNTech received a downgrade from HSBC research analysts on Monday. They changed their rating from Buy to hold in a research report distributed to clients and investors, as reported by Marketbeat.com. Additionally, they revised their price target for the stock from $124.00 to $111.00. This indicates a more neutral stance on BioNTech's prospects, reflecting a potential shift in market sentiment or the analysts' assessment of the company's current position.